Masculinized dominant females in a cooperatively breeding species N AUBIN‐HORTH, JK Desjardins, YM Martei, S Balshine, HA Hofmann Molecular Ecology 16 (7), 1349-1358, 2007 | 133 | 2007 |
Breast cancer in low-and middle-income countries: why we need pathology capability to solve this challenge YM Martei, LE Pace, JE Brock, LN Shulman Clinics in laboratory medicine 38 (1), 161-173, 2018 | 87 | 2018 |
Cancer care workforce in Africa: perspectives from a global survey V Vanderpuye, N Hammad, Y Martei, WM Hopman, A Fundytus, ... Infectious agents and cancer 14, 1-8, 2019 | 48 | 2019 |
Fear of mastectomy associated with delayed breast cancer presentation among Ghanaian women YM Martei, V Vanderpuye, BA Jones The oncologist 23 (12), 1446-1452, 2018 | 47 | 2018 |
Availability of WHO essential medicines for cancer treatment in Botswana YM Martei, S Chiyapo, S Grover, D Ramogola-Masire, S Dryden-Peterson, ... Journal of global oncology 4, 1-8, 2018 | 40 | 2018 |
Breast cancer and HIV in Sub-Saharan Africa: a complex relationship S Grover, YM Martei, P Puri, P Prabhakar, M Mutebi, OD Balogun, ... Journal of global oncology 4, 1-11, 2017 | 40 | 2017 |
Patent pooling to increase access to essential medicines E Burrone, D Gotham, A Gray, K de Joncheere, N Magrini, YM Martei, ... Bulletin of the World Health Organization 97 (8), 575, 2019 | 34 | 2019 |
Training global oncologists: addressing the global cancer control problem S Grover, OD Balogun, K Yamoah, R Groen, M Shah, D Rodin, Y Martei, ... Frontiers in oncology 5, 80, 2015 | 27 | 2015 |
Impact of COVID-19 on cancer care delivery in Africa: a cross-sectional survey of oncology providers in Africa YM Martei, TJ Rick, T Fadelu, MS Ezzi, N Hammad, NS Quadri, ... JCO Global Oncology 7, 368-377, 2021 | 26 | 2021 |
Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes YM Martei, JM Matro Breast Cancer: Targets and Therapy, 337-343, 2015 | 21 | 2015 |
Shortages and price variability of essential cytotoxic medicines for treating children with cancers YM Martei, K Iwamoto, RD Barr, JT Wiernkowski, J Robertson BMJ global health 5 (11), e003282, 2020 | 20 | 2020 |
Breast cancer pathology turnaround time in Botswana YM Martei, M Narasimhamurthy, P Prabhakar, J Hutson, DI Setlhako, ... Journal of Global Oncology 4, 1-7, 2017 | 16 | 2017 |
Impact of essential medicine stock outs on cancer therapy delivery in a resource-limited setting YM Martei, S Grover, WB Bilker, B Monare, DI Setlhako, TB Ralefala, ... Journal of global oncology 5, 1-11, 2019 | 14 | 2019 |
Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana RK Bhatia, M Narasimhamurthy, YM Martei, P Prabhakar, J Hutson, ... Infectious agents and cancer 14, 1-8, 2019 | 13 | 2019 |
Methodology to forecast volume and cost of cancer drugs in low-and middle-income countries YM Martei, S Chiyapo, S Grover, C Hanna, S Dryden-Peterson, ... Journal of Global Oncology 4, 1-8, 2018 | 13 | 2018 |
Access to and Affordability of world health organization essential medicines for cancer in sub-Saharan Africa: examples from Kenya, Rwanda, and Uganda DA Kizub, S Naik, AA Abogan, D Pain, S Sammut, LN Shulman, ... The oncologist 27 (11), 958-970, 2022 | 12 | 2022 |
Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal YM Martei, B Dauda, V Vanderpuye BMC cancer 22 (1), 203, 2022 | 12 | 2022 |
Cancer care and control as a human right: recognizing global oncology as an academic field AE Eniu, YM Martei, EL Trimble, LN Shulman American Society of Clinical Oncology Educational Book 37, 409-415, 2017 | 12 | 2017 |
Provider barriers and facilitators of breast cancer guideline-concordant therapy delivery in Botswana: a consolidated framework for implementation research analysis T Ralefala, L Mokokwe, S Jammalamadugu, D Legobere, WS Motlhwa, ... The Oncologist 26 (12), e2200-e2208, 2021 | 10 | 2021 |
Essential medicines list in national cancer control plans: a secondary analysis from a global study E Razis, M Kassapian, C Andriakopoulou, YM Martei, SJ Zurn, ... The Lancet Oncology 23 (3), e144-154, 2022 | 9 | 2022 |